Ebola virus modulates transforming growth factor β signaling and cellular markers of mesenchyme-like transition in hepatocytes

Journal of Virology

Volumn 88, Issue 17, 2014, Pages 9877-9892

  Kindrachuk, Jason ^a   Wahl Jensen, Victoria ^a,e   Safronetz, David ^b   Trost, Brett ^c   Hoenen, Thomas ^b   Arsenault, Ryan ^c,d   Feldmann, Friederike ^b   Traynor, Dawn ^a   Postnikova, Elena ^a   Kusalik, Anthony ^c   Napper, Scott ^c,d   Blaney, Joseph E ^a   Feldmann, Heinz ^b   Jahrling, Peter B ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

^e National Biodefense Analysis and Countermeasures Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; BAGG ALBINO MOUSE; CELL DIFFERENTIATION; DISEASE MODEL; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; GENE EXPRESSION PROFILING; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; HUMAN; LIVER CELL; MESODERM; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; EBOLAVIRUS; GENE EXPRESSION PROFILING; HEMORRHAGIC FEVER, EBOLA; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; MESODERM; MICE, INBRED BALB C; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84907007449     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01410-14     Document Type: Article

References (68)

1. Kuhn J, Becker S, Ebihara H, Geisbert TW, Jahrling PB, Kawaoka Y, Netesov SV, Nichol ST, Peters CJ, Volchkov VE, Ksiazek TG. 2012. Filoviridae, p 665-671. In King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ (ed), Virus taxonomy: classification and nomenclature of viruses. Ninth report of the International Committee on Taxonomy of Viruses. Academic Press, London, United Kingdom.
2. Feldmann H, Geisbert TW. 2011. Ebola haemorrhagic fever. Lancet 377:849-862. http://dx.doi.org/10.1016/S0140-6736(10)60667-8.
3. Gatherer D. 2 May 2014. The 2014 Ebola virus disease outbreak in west Africa. J. Gen. Virolhttp://dx.doi.org/10.1099/vir.0.067199-0.
4. Wasswa H. 2012. Uganda gears up to contain Ebola epidemic as fears of spread cause panic. BMJ 345:e5210. http://dx.doi.org/10.1136/bmj.e5210.
5. Anonymous. 2009. Imported case of Marburg hemorrhagic fever-Colorado, 2008. MMWR Morb. Mortal. Wkly. Rep. 58:1377-1381.
6. Timen A, Koopmans MP, Vossen AC, van Doornum GJ, Gunther S, van den Berkmortel F, Verduin KM, Dittrich S, Emmerich P, Osterhaus AD, van Dissel JT, Coutinho RA. 2009. Response to imported case of Marburg hemorrhagic fever, the Netherlands. Emerg. Infect. Dis. 15: 1171-1175. http://dx.doi.org/10.3201/eid1508.090015.
7. Hoenen T, Groseth A, Feldmann H. 2012. Current Ebola vaccines. Expert Opin. Biol. Ther. 12:859-872. http://dx.doi.org/10.1517/14712598.2012.685152.
8. Kondratowicz AS, Maury WJ. 2012. Ebolavirus: a brief review of novel therapeutic targets. Future Microbiol. 7:1-4. http://dx.doi.org/10.2217/fmb.11.110.
9. Takada A, Kawaoka Y. 2001. The pathogenesis of Ebola hemorrhagic fever.TrendsMicrobiol.9:506-511.http://dx.doi.org/10.1016/S0966-842X (01)02201-6.
10. Aleksandrowicz P, Wolf K, Falzarano D, Feldmann H, Seebach J, Schnittler H. 2008. Viral haemorrhagic fever and vascular alterations. Hamostaseologie 28:77-84.
11. Mahanty S, Hutchinson K, Agarwal S, McRae M, Rollin PE, Pulendran B. 2003. Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J. Immunol. 170:2797-2801. http://dx.doi.org/10.4049/jimmunol.170.6.2797.
12. Rubins KH, Hensley LE, Wahl-Jensen V, Daddario DiCaprio KM, Young HA, Reed DS, Jahrling PB, Brown PO, Relman DA, Geisbert TW. 2007. The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever. Genome Biol. 8:R174. http://dx.doi.org/10.1186/gb-2007-8-8-r174.
13. Villinger F, Rollin PE, Brar SS, Chikkala NF, Winter J, Sundstrom JB, Zaki SR, Swanepoel R, Ansari AA, Peters CJ. 1999. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J. Infect. Dis. 179(Suppl 1):S188-S191.
14. Baize S, Leroy EM, Georges AJ, Georges-Courbot MC, Capron M, Bedjabaga I, Lansoud-Soukate J, Mavoungou E. 2002. Inflammatory responses in Ebola virus-infected patients. Clin. Exp. Immunol. 128:163-168. http://dx.doi.org/10.1046/j.1365-2249.2002.01800.x.
15. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Larsen T, Kagan E, Hensley LE. 2003. Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am. J. Pathol. 163:2371-2382. http://dx.doi.org/10.1016/S0002-9440(10)63592-4.
16. Gupta M, Mahanty S, Ahmed R, Rollin PE. 2001. Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with Ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-ICinduced IFN-alpha in vitro. Virology 284:20-25. http://dx.doi.org/10.1006/viro.2001.0836.
17. Hensley LE, Young HA, Jahrling PB, Geisbert TW. 2002. Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol. Lett. 80:169-179. http://dx.doi.org/10.1016/S0165-2478(01)00327-3.
18. Schnittler HJ, Feldmann H. 1999. Molecular pathogenesis of filovirus infections: role of macrophages and endothelial cells. Curr. Topics Microbiol. Immunol. 235:175-204.
19. Bowen ET, Platt GS, Simpson DI, McArdell LB, Raymond RT. 1978. Ebola haemorrhagic fever: experimental infection of monkeys. Trans. R. Soc. Trop. Med. Hyg. 72:188-191. http://dx.doi.org/10.1016/0035-9203(78)90058-5.
20. Ellis DS, Simpson IH, Francis DP, Knobloch J, Bowen ET, Lolik P, Deng IM. 1978. Ultrastructure of Ebola virus particles in human liver. J. Clin. Pathol. 31:201-208. http://dx.doi.org/10.1136/jcp.31.3.201.
21. Stroher U, West E, Bugany H, Klenk HD, Schnittler HJ, Feldmann H. 2001. Infection and activation of monocytes by Marburg and Ebola viruses. J. Virol. 75:11025-11033. http://dx.doi.org/10.1128/JVI.75.22.11025-11033.2001.
22. Wyers M, Formenty P, Cherel Y, Guigand L, Fernandez B, Boesch C, Le Guenno B. 1999. Histopathological and immunohistochemical studies of lesions associated with Ebola virus in a naturally infected chimpanzee. J. Infect. Dis. 179(Suppl 1):S54-S59.
23. Hartman AL, Ling L, Nichol ST, Hibberd ML. 2008. Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein. J. Virol. 82:5348-5358. http://dx.doi.org/10.1128/JVI.00215-08.
24. Kash JC, Muhlberger E, Carter V, Grosch M, Perwitasari O, Proll SC, Thomas MJ, Weber F, Klenk HD, Katze MG. 2006. Global suppression of the host antiviral response by Ebola-and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence. J. Virol. 80:3009-3020. http://dx.doi.org/10.1128/JVI.80.6.3009-3020.2006.
25. Wahl-Jensen V, Kurz S, Feldmann F, Buehler LK, Kindrachuk J, De-Filippis V, da Silva Correia J, Fruh K, Kuhn JH, Burton DR, Feldmann H. 2011. Ebola virion attachment and entry into human macrophages profoundly effects early cellular gene expression. PLoS Negl. Trop. Dis. 5:e1359. http://dx.doi.org/10.1371/journal.pntd.0001359.
26. Kindrachuk J, Napper S. 2013. Probing the kinome for biomakers and therapeutic targets: peptide arrays for global phosphorylation-mediated signal transduction. In Horvatovich P, Bischoff R (ed), Comprehensive biomarker discovery and validation for clinical applications. Royal Society of Chemistry, Cambridge, United Kingdom.
27. Piersma SR, Labots M, Verheul HM, Jimenez CR. 2010. Strategies for kinome profiling in cancer and potential clinical applications: chemical proteomics and array-based methods. Anal. Bioanal Chem. 397:3163-3171. http://dx.doi.org/10.1007/s00216-010-3784-7.
28. Arsenault R, Griebel P, Napper S. 2011. Peptide arrays for kinome analysis: new opportunities and remaining challenges. Proteomics 11: 4595-4609. http://dx.doi.org/10.1002/pmic.201100296.
29. Kindrachuk J, Arsenault R, Kusalik A, Kindrachuk KN, Trost B, Napper S, Jahrling PB, Blaney JE. 2012. Systems kinomics demonstrates Congo Basin monkeypox virus infection selectively modulates host cell signaling responses as compared to West African monkeypox virus. Mol. Cell. Proteomics 11:M111.015701. http://dx.doi.org/10.1074/mcp.M111.015701.
30. Ryabchikova EI, Kolesnikova LV, Luchko SV. 1999. An analysis of features of pathogenesis in two animal models of Ebola virus infection. J. Infect. Dis. 179(Suppl 1):S199-S202. http://dx.doi.org/10.1086/514293.
31. U.S. Department of Health and Human Services. 2009. Biosafety in microbiological and biomedical laboratories, 5th ed. U.S. Department of Health and Human Services, Washington, DC.
32. Li Y, Arsenault RJ, Trost B, Slind J, Griebel PJ, Napper S, Kusalik A. 2012. A systematic approach for analysis of peptide array kinome data. Sci. Signal. 5:pl2. http://dx.doi.org/10.1126/scisignal.2002429.
33. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. 2002. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18(Suppl 1): S96-S104. http://dx.doi.org/10.1093/bioinformatics/18.suppl_1.S96.
34. Trost B, Kindrachuk J, Maattanen P, Napper S, Kusalik A. 2013. PIIKA 2: an expanded, web-based platform for analysis of kinome microarray data. PLoS One 8:e80837. http://dx.doi.org/10.1371/journal.pone.0080837.
35. McQuitty L. 1996. Similarity analysis by reciprocal pairs for discrete and continuous data. Educ. Psychol. Meas. 26:825-831.
36. Dudley AC, Thomas D, Best J, Jenkins A. 2005. A VEGF/JAK2/STAT5 axis may partially mediate endothelial cell tolerance to hypoxia. Biochem. J. 390:427-436. http://dx.doi.org/10.1042/BJ20050351.
37. Groseth A, Hoenen T, Alimonti JB, Zielecki F, Ebihara H, Theriault S, Stroher U, Becker S, Feldmann H. 2007. In vitro evaluation of antisense RNAefficacy against filovirus infection, by use of reverse genetics. J. Infect. Dis. 196(Suppl 2):S382-S389. http://dx.doi.org/10.1086/520604.
38. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
39. Arsenault RJ, Li Y, Bell K, Doig K, Potter A, Griebel PJ, Kusalik A, Napper S. 2012. Mycobacterium avium subsp. paratuberculosis inhibits gamma interferon-induced signaling in bovine monocytes: insights into the cellular mechanisms of Johne's disease. Infect. Immun. 80:3039-3048. http://dx.doi.org/10.1128/IAI.00406-12.
40. Lynn DJ, Winsor GL, Chan C, Richard N, Laird MR, Barsky A, Gardy JL, Roche FM, Chan TH, Shah N, Lo R, Naseer M, Que J, Yau M, Acab M, Tulpan D, Whiteside MD, Chikatamarla A, Mah B, Munzner T, Hokamp K, Hancock RE, Brinkman FS. 2008. InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Mol. Syst. Biol. 4:218. http://dx.doi.org/10.1038/msb.2008.55.
41. Donovan D, Harmey JH, Toomey D, Osborne DH, Redmond HP, Bouchier-Hayes DJ. 1997. TGF beta-1 regulation of VEGF production by breast cancer cells. Ann. Surg. Oncol. 4:621-627. http://dx.doi.org/10.1007/BF02303745.
42. Sanchez-Elsner T, Botella LM, Velasco B, Corbi A, Attisano L, Bernabeu C. 2001. Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J. Biol. Chem. 276:38527-38535. http://dx.doi.org/10.1074/jbc.M104536200.
43. Bray M, Davis K, Geisbert T, Schmaljohn C, Huggins J. 1998. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J. Infect. Dis. 178:651-661. http://dx.doi.org/10.1086/515386.
44. Kaimori A, Potter J, Kaimori JY, Wang C, Mezey E, Koteish A. 2007. Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J. Biol. Chem. 282:22089-22101. http://dx.doi.org/10.1074/jbc.M700998200.
45. Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, Tanjore H, Kalluri R. 2007. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 282:23337-23347. http://dx.doi.org/10.1074/jbc.M700194200.
46. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. 2006. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 24:99-146. http://dx.doi.org/10.1146/annurev.immunol.24.021605.090737.
47. Borthwick LA, Sunny SS, Oliphant V, Perry J, Brodlie M, Johnson GE, Ward C, Gould K, Corris PA, De Soyza A, Fisher AJ. 2011. Pseudomonas aeruginosa accentuates epithelial-to-mesenchymal transition in the airway. Eur. Respir. J. 37:1237-1247. http://dx.doi.org/10.1183/09031936.00088410.
48. Xu J, Lamouille S, Derynck R. 2009. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19:156-172. http://dx.doi.org/10.1038/cr.2009.5.
49. Liu S, Yang W, Shen L, Turner JR, Coyne CB, Wang T. 2009. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J. Virol. 83:2011-2014. http://dx.doi.org/10.1128/JVI.01888-08.
50. Borthwick LA, Gardner A, De Soyza A, Mann DA, Fisher AJ. 2012. Transforming growth factor-beta1 (TGF-beta1) driven epithelial to mesenchymal transition (EMT) is accentuated by tumour necrosis factor alpha (TNFalpha) via crosstalk between the SMAD and NF-kappaB pathways. Cancer Microenviron. 5:45-57. http://dx.doi.org/10.1007/s12307-011-0080-9.
51. Kuhn JH. 2008. Filoviruses. A compendium of 40 years of epidemiological, clinical, and laboratory studies. Arch. Virol. Suppl. 20:13-360.
52. Davis KJ, Anderson AO, Geisbert TW, Steele KE, Geisbert JB, Vogel P, Connolly BM, Huggins JW, Jahrling PB, Jaax NK. 1997. Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells. Arch. Pathol. Lab. Med. 121:805-819.
53. Ito H, Watanabe S, Takada A, Kawaoka Y. 2001. Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J. Virol. 75:1576-1580. http://dx.doi.org/10.1128/JVI.75.3.1576-1580.2001.
54. Johnson E, Jaax N, White J, Jahrling P. 1995. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int. J. Exp. Pathol. 76:227-236.
55. Ryabchikova E, Kolesnikova L, Smolina M, Tkachev V, Pereboeva L, Baranova S, Grazhdantseva A, Rassadkin Y. 1996. Ebola virus infection in guinea pigs: presumable role of granulomatous inflammation in pathogenesis. Arch. Virol. 141:909-921. http://dx.doi.org/10.1007/BF01718165.
56. Steele KE, Anderson AO, Mohamadzadeh M. 2009. Fibroblastic reticular cell infection by hemorrhagic fever viruses. Immunotherapy 1:187-197. http://dx.doi.org/10.2217/1750743X.1.2.187.
57. Zhao X, Nicholls JM, Chen YG. 2008. Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling. J. Biol. Chem. 283:3272-3280. http://dx.doi.org/10.1074/jbc.M708033200.
58. Zhang X, Daucher M, Baeza J, Kim CW, Russell R, Kottilil S. 2012. Human immunodeficiency virus enhances hepatitis C virus replication by differential regulation of IFN and TGF family genes. J. Med. Virol. 84: 1344-1352. http://dx.doi.org/10.1002/jmv.23315.
59. Mohamadzadeh M. 2009. Potential factors induced by filoviruses that lead to immune suppression. Curr. Mol. Med. 9:174-185. http://dx.doi.org/10.2174/156652409787581628.
60. Ebihara H, Zivcec M, Gardner D, Falzarano D, Lacasse R, Rosenke R, Long D, Haddock E, Fischer E, Kawaoka Y, Feldmann H. 2012. A Syrian golden hamster model recapitulating ebola hemorrhagic fever. J. Infect. Dis. 207:306-318. http://dx.doi.org/10.1093/infdis/jis626.
61. Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2:442-454. http://dx.doi.org/10.1038/nrc822.
62. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R. 2003. BMP-7 counteracts TGF-beta1-induced epithelial-tomesenchymal transition and reverses chronic renal injury. Nat. Med. 9:964-968. http://dx.doi.org/10.1038/nm888.
63. Olejnik J, Ryabchikova E, Corley RB, Muhlberger E. 2011. Intracellular events and cell fate in filovirus infection. Viruses 3:1501-1531. http://dx.doi.org/10.3390/v3081501.
64. Hassan M, Selimovic D, Ghozlan H, Abdel-Kader O. 2009. Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways. Hepatology 49:1469-1482. http://dx.doi.org/10.1002/hep.22849.
65. ten Dijke P, Arthur HM. 2007. Extracellular control of TGFbeta signalling in vascular development and disease. Nat. Rev. Mol. Cell Biol. 8:857-869. http://dx.doi.org/10.1038/nrm2262.
66. Short KR, Kroeze EJ, Fouchier RA, Kuiken T. 2014. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect. Dis. 14:57-69. http://dx.doi.org/10.1016/S1473-3099(13)70286-X.
67. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. 2000. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275:36803-36810. http://dx.doi.org/10.1074/jbc.M005912200.
68. Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL. 2002. p38 mitogenactivated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration. J. Cell Sci. 115:3193-3206.